Pragati Raw Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-07-2024
- Paid Up Capital ₹ 1.51 M
as on 29-07-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.38 Cr
as on 29-07-2024
- Satisfied Charges ₹ 1.00 Cr
as on 29-07-2024
- Revenue -42.31%
(FY 2023)
- Profit -138.14%
(FY 2023)
- Ebitda -165.15%
(FY 2023)
- Net Worth -5.59%
(FY 2023)
- Total Assets -2.45%
(FY 2023)
About Pragati Raw Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.51 M.
The company currently has active open charges totaling ₹26.38 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemal Mehta, Saumil Mehta, and Mohil Mehta serve as directors at the Company.
- CIN/LLPIN
U52311MH1999PTC120384
- Company No.
120384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pragati Raw Pharma Private Limited offer?
Pragati Raw Pharma Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Flavours & Aromatics, Artificial Sweetener, Food Preservative, Organic and Inorganic Solvents, Alcohol Solvents, Industrial Chemicals & Supplies, Biocides, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Pragati Raw Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemal Mehta  | Director | 17-Jun-1999 | Current |
| Saumil Mehta | Director | 20-Jun-2017 | Current |
| Mohil Mehta | Director | 05-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Pragati Raw Pharma.
Pragati Raw Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.31% decrease. The company also saw a substantial fall in profitability, with a 138.14% decrease in profit. The company's net worth dipped by a decrease of 5.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pragati Raw Pharma?
In 2023, Pragati Raw Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Apr 2018 | ₹7.75 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Jul 2011 | ₹4.13 Cr | Open |
Hdfc Bank Limited Creation Date: 06 Apr 2010 | ₹4.50 Cr | Open |
How Many Employees Work at Pragati Raw Pharma?
Unlock and access historical data on people associated with Pragati Raw Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pragati Raw Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pragati Raw Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
